AI in Healthcare and Life Sciences Podcast

Emerj Technology Research

The AI in Healthcare and Life Sciences is for non-technical leaders interested in where AI is creating an impact for patients, for business workflows, and for the bottom line. Global Fortune 500 healthcare and life sciences leaders join Emerj AI Research team (and CEO Daniel Faggella) to share where they're seeing AI impact today, as well as best-practices for AI adoption and ROI measurement in healthcare and pharma. Visit our advertising page to learn more about reaching our executive audience of AI adopters in the world's largest banking and insurance firms: https://emerj.com/advertise

  1. AI-Native Discovery in Pharma - with Alister Campbell of Dotmatics

    FEB 5

    AI-Native Discovery in Pharma - with Alister Campbell of Dotmatics

    Today's guest is Alister Campbell, Vice President, Global Head of Science and Technology at Dotmatics. Campbell works at the intersection of scientific R&D, data strategy, and applied AI across the drug discovery lifecycle. Alister joins Emerj Client Narrative & Content Strategy Lead Nick Gertsch to discuss how data and AI are shifting pharma R&D from linear, empirical workflows toward tighter, more predictive discovery loops where experiments, simulation, and modeling inform decisions earlier and faster. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    27 min
  2. Leading Bold Change and Human-Centered Innovation in Healthcare - with Dr. Imamu Tomlinson of Vituity

    JAN 1

    Leading Bold Change and Human-Centered Innovation in Healthcare - with Dr. Imamu Tomlinson of Vituity

    Today's guest is Dr. Imamu Tomlinson, CEO of Vituity and President of the Vituity Cares Foundation. Vituity is a physician-owned multispecialty partnership with 6,000+ clinicians across 690 locations. Dr. Tomlinson joins Emerj Editorial Director Marilie Fouché to unpack leadership for driving AI-enabled innovation in healthcare's slow ecosystem. Dr. Tomlinson also shares practical takeaways like channeling "disagreeableness" into questions, celebrating early data wins for buy-in, and using AI to offload transactional tasks — freeing time for empathy and human-centered decisions across 13 million annual encounters. Want to share your AI adoption story with executive peers? Click emerj.com/ex2 for more information and to be a potential future guest on Emerj's flagship 'AI in Business' podcast! Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

    22 min
  3. Reducing Audit Friction and Driving Accountability with AI in Healthcare – with Yasemin Agatan of AdaptHealth

    12/04/2025

    Reducing Audit Friction and Driving Accountability with AI in Healthcare – with Yasemin Agatan of AdaptHealth

    Today's guest is Yasemin Agatan, Senior Vice President of Internal Audit at AdaptHealth, a provider of home medical equipment, supplies, and related services supporting patients living at home. Yasemin brings extensive experience in audit, compliance, and operational risk management within the healthcare sector. She joins Emerj Editorial Director Matthew DeMello to discuss how enterprise leaders can leverage data and AI to improve audit workflows, enhance transparency, and manage risk more effectively. Yasemin also highlights practical approaches for organizations, including improving data visibility, implementing structured, explainable processes, and using AI to identify exceptions and inefficiencies, driving measurable gains in speed, accountability, and operational performance. Want to share your AI adoption story with executive peers? Click emerj.com/ex2 for more information and to be a potential future guest on Emerj's flagship 'AI in Business' podcast!

    30 min
  4. Driving AI from Pilots to Business Impact in Pharma – with Alyssa Fenoglio of Teva Pharmaceuticals

    11/06/2025

    Driving AI from Pilots to Business Impact in Pharma – with Alyssa Fenoglio of Teva Pharmaceuticals

    Today's guest is Alyssa Fenoglio, VP, Global Head of Digital Commercial at Teva Pharmaceuticals. Teva is a global pharmaceutical company delivering both generic and specialty medicines across more than 60 countries. Alyssa joins Emerj CEO and Head of Research Daniel Faggella to discuss the unique challenges of digital transformation in life sciences and how organizations can leverage data and AI to create real business impact. She also shares practical strategies for securing leadership support, linking AI pilots to measurable business outcomes, and building cross-functional teams to drive innovation responsibly and at scale. Want to share your AI adoption story with executive peers? Click emerj.com/e2 for more information and to be a potential future guest on Emerj's flagship 'AI in Business' podcast! Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

    24 min
  5. Driving Audit Workflows in the Era of Agentic AI and IoT for Healthcare - with Yasemin Agatan of Adapt Health

    10/02/2025

    Driving Audit Workflows in the Era of Agentic AI and IoT for Healthcare - with Yasemin Agatan of Adapt Health

    Internal audit sits at the crossroads of regulation, data, and business outcomes—nowhere more than in healthcare and medical devices. Yasemin Agatan, Sr. Vice President of Internal Audit at AdaptHealth, joins Emerj Editorial Director Matthew DeMello to unpack what an "AI-ready" audit looks like in one of the most complex and regulated environments. Yasemin lays out today's top pressures: rapidly shifting FDA and HIPAA requirements, thorny revenue recognition and reimbursement models, multi-party contracts, and a deluge of device and platform data. She then maps where AI is already moving the needle—NLP for coding accuracy, automated claims checks, anomaly detection that shortens audit cycles—and how internal audit can lead with governance: creating an AI inventory, partnering with InfoSec, compliance, legal, and data teams, and putting privacy and data minimization at the core. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    24 min
  6. Dangers of Unchecked AI Development When Politics Meets Machine Learning - with John-Clark Levin of the Yorktown Institute

    09/04/2025

    Dangers of Unchecked AI Development When Politics Meets Machine Learning - with John-Clark Levin of the Yorktown Institute

    In this episode of the AI in Healthcare and Life Sciences podcast, host Matthew DeMello speaks with John-Clark Levin, Fellow at the Yorktown Institute and researcher at Kurzweil Research, about the intersection of U.S. politics, AI development, and biosecurity. Levin outlines why the coming years may prove decisive for artificial general intelligence (AGI) and how political volatility under the current administration could directly impact AI safety and regulation. He explains the unique risks of authoritarian tendencies in shaping AI policy, particularly when it comes to epistemics—how governments decide what's true and which advisors they trust. Want to share your AI adoption story with executive peers? Click emerj.com/ex2 for more information and to be a potential future guest on Emerj's flagship' AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    1 hr
  7. Bridging the AI Trust Gap in Life Sciences Workflows - with John-Clark Levin of Kurzweil Technologies

    08/07/2025

    Bridging the AI Trust Gap in Life Sciences Workflows - with John-Clark Levin of Kurzweil Technologies

    Today's guest is John-Clark Levin, Research Lead at Kurzweil Technologies. Kurzweil Technologies, Inc. (KTI) is a research and development company developing and marketing technologies in pattern recognition and artificial intelligence. In this episode, John-Clark unpacks the challenges of deploying AI in healthcare, focusing on reliability, risk tolerance, and the gap between model performance and real-world trust. He explores why even small error rates can derail adoption in high-stakes settings and how legal, institutional, and educational barriers often slow progress more than the technology itself. Want to share your AI adoption story with executive peers? Click emerj.com/ex2 for more information and to be a potential future guest on Emerj's flagship' AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    35 min
  8. Human-Centered AI and the Path to Transformation - with Francesco Tisiot of Aiven

    07/03/2025

    Human-Centered AI and the Path to Transformation - with Francesco Tisiot of Aiven

    Today's guest is Francesco Tisiot, Field CTO at Aiven. Aiven provides fully managed, open-source data infrastructure on all major clouds. Their platform enables organizations to scale quickly, securely, and cost-effectively — freeing teams to focus on delivering AI applications and business outcomes. Francesco returns to the program to share a pragmatic perspective on AI adoption in highly regulated industries. He outlines how generative AI can eliminate repetitive tasks, accelerate decision-making, and improve employee engagement — without compromising trust or compliance. From co-pilot interfaces to human-in-the-loop models, Francesco emphasizes where AI can provide value while keeping clinicians and analysts at the center of critical decisions. The conversation also covers the pitfalls of scaling AI too quickly. Francesco breaks down the technical and economic challenges that arise when moving from small pilots to enterprise-wide deployment. He explains why foundational data architecture, clearly defined KPIs, and regulatory foresight are essential for sustainable adoption. Want to share your AI adoption story with executive peers? Click emerj.com/ex2 for more information and to be a potential future guest on Emerj's flagship' AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    19 min
See All (26)

Ratings & Reviews

3.8
out of 5
4 Ratings

About

The AI in Healthcare and Life Sciences is for non-technical leaders interested in where AI is creating an impact for patients, for business workflows, and for the bottom line. Global Fortune 500 healthcare and life sciences leaders join Emerj AI Research team (and CEO Daniel Faggella) to share where they're seeing AI impact today, as well as best-practices for AI adoption and ROI measurement in healthcare and pharma. Visit our advertising page to learn more about reaching our executive audience of AI adopters in the world's largest banking and insurance firms: https://emerj.com/advertise

Information